Clinical Strategy and New Product Planning

Clinical Strategy and New Product Planning (NPP) teams' decisions are critical to any pharmaceutical company’s medium-term success and longer-term trajectory, in turn driving company valuation.

We believe that financial and demand assessments should be built on solid assumptions and hence a deep understanding of the evolving treatment landscape, potential clinical use cases, in order to withstand even rigorous pressure testing.

However, future treatment and regulatory landscapes including competitor developments are intrinsically hard to predict, so portfolio/ asset development strategies need to consider (or even embrace) those uncertainties.

We help Clinical and NPP teams to create a thorough foundational disease area understanding as well as clear product profiles (TPPs) and positioning.